Contraceptives Market to Witness Exponential Growth US$ 62 Billion by 2033 | Fact.MR

The global contraceptives market (避妊薬市場) is projected to grow significantly, with its value expected to rise from US$ 33 billion to US$ 62 billion by 2033. This growth is primarily attributed to robust government campaigns and programs aimed at improving women's and children's health. Government initiatives and programs promoting women's and children's health are driving the adoption of contraceptive methods. Copper intrauterine devices (IUDs) are particularly popular among women who prefer non-hormonal options to avoid potential side effects.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4719

Contraception, also known as fertility control or birth control, involves the use of medication or devices to prevent pregnancy. Various contraceptive methods are available, and the most suitable method depends on an individual's health and circumstances. These methods work by disrupting the normal fertilization process between sperm and egg, thereby preventing conception.

Key Driving Forces Accelerating the Market Growth:

Growing Awareness: Increased awareness about family planning and contraception methods has spurred demand for contraceptives. Educational campaigns have played a crucial role in promoting contraceptive use and empowering individuals to make informed decisions.

Technological Advancements: Advancements in contraceptive technologies, such as the development of long-acting reversible contraceptives (LARCs) like intrauterine devices (IUDs) and implants, offer improved convenience, effectiveness, and reduced side effects, driving adoption rates.

Regional Dynamics: Regions like North America, with a 50% share of the global market, witness growth due to rising unintended pregnancies, demand for reversible contraceptives, and government initiatives providing funding for family planning services.

Government Programs: Government programs and policies promoting access to contraceptives have fueled market growth. Subsidized programs and increased funding for family planning services have made contraceptives more accessible and affordable.

Workforce Participation: The increasing number of women in the workforce has led to higher demand for contraceptives. Women pursuing careers opt for contraception to control reproductive choices and plan for desired family sizes.

Changing Social Attitudes: Shifting social attitudes towards sexual health and reproductive rights have contributed to market growth. Discussions on gender equality, individual autonomy, and women's empowerment have driven more people to seek contraceptive options to exercise control over their reproductive health.

Key Companies Profiled in This Report

Evofem Biosciences
CooperSurgical, Inc.
Actavis, Inc.
Medisafe Distribution Inc.
Mayer Laboratories, Inc.
Mylan
Allergan Plc.
Veru Inc.
CooperSurgical, Inc.
Pfizer Inc.

Competitive Landscape:

Competition in the contraceptive market (피임약 시장) drives innovation and product development, as companies strive to offer new and improved options with greater effectiveness, convenience, safety, and fewer side effects. Key players focus on research and development (R&D) to introduce modern devices and enhance product standards. Acquisitions and collaborations are common strategies to strengthen market presence.

For example, in 2021, Cooper Surgical Inc. acquired Generate Life Sciences, enhancing its reproductive section. Clue introduced a digital birth control method, providing users with an ovulation tracker. Pfizer Inc. launched Sayana Press, the first injectable contraceptive for women in the U.K., and is studying levonorgestrel and Ethinyl estradiol as potential oral contraceptives. Merck & Co, Inc. offers various contraceptive options, including oral pills, vaginal rings, intrauterine devices, and sub-dermal implants. Cipla manufactures Crisanta, an oral contraceptive containing Drospirenone, which prevents fertilization and induces hormonal changes to prevent pregnancy.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=4719

Key Segments of Contraceptives (Markt für Verhütungsmittel) Industry Research

By Product :

Contraceptive Drugs

Contraceptive Devices

By Distribution Channel :

Hospital Pharmacies

Independent Pharmacies

Online Platforms

Clinics

Others

By Region :

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.